What are the DSM‑5 criteria for mood disorders, including major depressive episode, persistent depressive disorder, bipolar I disorder, bipolar II disorder, and cyclothymic disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM Criteria for Mood Disorders

The DSM-5 separates mood disorders into two distinct chapters: "Depressive Disorders" and "Bipolar and Related Disorders," replacing the unified "Mood Disorders" chapter from DSM-IV. This structural change reflects a fundamental reconceptualization of these conditions as separate diagnostic entities rather than variations of a single disorder spectrum 1, 2, 3.

Major Depressive Disorder (MDD)

For MDD diagnosis, you must identify 5 or more specific symptoms present during the same 2-week period, representing a change from previous functioning, with at least one symptom being either depressed mood or loss of interest/pleasure 1, 4.

Core Diagnostic Criteria:

The 9 symptoms to assess are:

  1. Depressed mood most of the day, nearly every day (in children/adolescents, can present as irritable mood)
  2. Markedly diminished interest or pleasure in all or nearly all activities most of the day, nearly every day
  3. Significant weight loss/gain (>5% body weight in a month) or appetite changes (in children, include failure to make expected weight gains)
  4. Insomnia or hypersomnia nearly every day
  5. Psychomotor agitation or retardation nearly every day (observable by others, not just subjective feelings)
  6. Fatigue or loss of energy nearly every day
  7. Feelings of worthlessness or inappropriate guilt (may be delusional) nearly every day
  8. Diminished ability to think, concentrate, or indecisiveness nearly every day
  9. Recurrent thoughts of death, suicidal ideation, suicide attempt, or specific plan 1, 4

Additional Required Criteria:

  • Symptoms cause clinically significant distress or impairment in social, occupational, or other important functioning
  • Symptoms are not due to direct physiologic effects of substances (drugs, medications) or general medical conditions (e.g., hypothyroidism)
  • Symptoms do not meet criteria for a mixed episode (simultaneous manic and depressive symptoms)
  • Not better accounted for by bereavement (though DSM-5 removed the bereavement exclusion, replacing it with clinical judgment to distinguish normal grief from pathological depression) 1, 5

Severity Classification:

Mild depression: 5-6 symptoms of mild severity with minimal functional impairment

Moderate depression: Symptom count and severity between mild and severe

Severe depression: All 9 symptoms present, OR presence of specific suicide plan/intent/recent attempt, psychotic symptoms, first-degree family history of bipolar disorder, or severe functional impairment (unable to leave home) 6

Persistent Depressive Disorder (Dysthymia)

DSM-5 created this new category to encompass both chronic depression and dysthymia from DSM-IV 5, 7. This diagnosis requires depressed mood on most days for at least 2 years in adults (1 year in children/adolescents) 4. The relationship between this diagnosis and concurrent MDD remains ambiguous in DSM-5, with conflicting guidance on whether both diagnoses should be assigned simultaneously when criteria for both are met 5.

Bipolar I Disorder

Bipolar I requires occurrence of at least one manic or mixed episode lasting at least 7 days (or any duration if hospitalization is required) 2. Depressive episodes are not required for diagnosis, though most patients experience them during their lifetime.

Manic Episode Criteria:

DSM-5 added a critical entry criterion: both abnormally elevated/irritable mood AND increased energy/activity must be present 8, 9. This represents a significant change that may reclassify some DSM-IV bipolar I patients to subdiagnostic categories.

The episode must include:

  • Distinct period of abnormally and persistently elevated, expansive, or irritable mood
  • Abnormally and persistently increased goal-directed activity or energy
  • Duration of at least 7 days (or any duration if hospitalization needed)
  • Represents significant departure from baseline functioning 2

Mixed Episode:

A period lasting 7 days or more where criteria for both manic and depressive episodes are simultaneously met 2. Note that DSM-5 eliminated the mixed episode as a separate entity, replacing it with a "mixed features" specifier 9.

Bipolar II Disorder

Bipolar II requires at least one hypomanic episode (lasting at least 4 days) and at least one major depressive episode, but no full manic or mixed episodes 2, 10, 2. This diagnosis was added to ICD-11 to harmonize with DSM-5 9.

Key Distinguishing Features from Bipolar I:

Bipolar II patients typically present with:

  • Later "bipolar" presentation and older age at first hypomania
  • More frequent depressive onset and early depressive episodes
  • Depressive predominant polarity
  • More chronic fluctuating course rather than episodic
  • Higher rates of rapid cycling
  • More antidepressant use and less mood stabilizer use during early course 11

Cyclothymic Disorder

While not extensively detailed in the provided evidence, cyclothymic disorder involves numerous periods of hypomanic symptoms and depressive symptoms that do not meet full criteria for hypomanic or depressive episodes, persisting for at least 2 years in adults.

Important Clinical Considerations:

Rapid cycling is defined as at least 4 mood episodes in 1 year, with episodes still meeting full duration criteria (e.g., 7 days for mania) 2. This differs from some pediatric literature definitions.

The bereavement exclusion was removed in DSM-5, replaced with clinical judgment to distinguish normal grief reactions from pathological depression requiring treatment 5, 9. This makes diagnosis less objective and more dependent on clinician assessment.

New DSM-5 specifiers include "with anxious distress," "with mixed features," and "with perinatal onset" (expanded from postnatal to include pregnancy onset) 5, 7.

References

Guideline

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

Research

[Mood disorders in the DSM-5].

Tijdschrift voor psychiatrie, 2014

Research

Bipolar disorders in DSM-5: strengths, problems and perspectives.

International journal of bipolar disorders, 2013

Research

Bipolar disorders in the new DSM-5 and ICD-11 classifications.

Revista de psiquiatria y salud mental, 2014

Related Questions

What are the changes in diagnosis of unspecified bipolar and related disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) 10 and 11?
What are the changes in the diagnosis of Bipolar I disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) versions 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) versions 10 and 11?
In a patient recently hospitalized for fluid overload and shortness of breath, with diagnoses of Bipolar II disorder, Generalized Anxiety Disorder, Psychophysiologic Insomnia, Cognitive Communication Deficit, Drug‑induced Subacute Dyskinesia, Morbid Obesity, and Moderate Recurrent Major Depressive Disorder, who is currently taking sertraline, loratadine, gabapentin, lisinopril, furosemide, topical nystatin‑triamcinolone and mupirocin, buspirone, aspirin, topiramate, albuterol, oxycodone‑acetaminophen, albuterol‑budesonide, and fluticasone propionate, would starting Austedo (lurasidone) be safe, and if so what initial dose should be used and what additional medications need to be started?
Can you draft a concise professional letter confirming that my patient is being treated for bipolar disorder, major depressive disorder, and generalized anxiety disorder, including the date of initial evaluation, current medication regimen, functional limitations, and recommended workplace accommodations?
What is the best mood stabilizer for a 52-year-old female resident with bipolar disorder who cycles between hypomania and mild depressive episodes?
What type of splint is appropriate for a mildly impacted distal radial metaphyseal fracture with mild dorsal angulation?
What is the appropriate management of a Strattera (atomoxetine) overdose?
Should a patient with chronic kidney disease stage 3a (eGFR ≈ 46 mL/min/1.73 m²) limit caffeine intake to ≤ 200 mg per day?
Can an inner‑ear infection such as labyrinthitis cause a sudden, unprovoked fall without ear pain in a 69‑year‑old?
How many true anaphylaxis events have occurred with intravenous iron therapy?
For how long can I safely use azelaic acid, and is lifelong use appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.